4.4 Article

Erythropoietin

Journal

COMPREHENSIVE PHYSIOLOGY
Volume 1, Issue 4, Pages 1759-1794

Publisher

WILEY
DOI: 10.1002/cphy.c100075

Keywords

-

Categories

Funding

  1. Swiss National Science Foundation
  2. National Center of Competence in Research Kidney.CH
  3. German Research Foundation [SFB 699]
  4. COST Action [TD0901]

Ask authors/readers for more resources

The hormone erythropoietin (Epo) is the main humoral regulator of erythropoiesis. It binds to specific receptors belonging to the cytokine receptor superfamily. Epo stimulates proliferation and differentiation of erythroid precursor cells, but may also bind to and exert some additional effects in nonhemopoietic tissues. It is mainly produced in the kidneys and to minor extents also in the liver and in the brain. The plasma concentration of erthyropoietin is inversely related to the oxygen content of the blood. The secretion of Epo into the circulation and hence its plasma concentrations are mainly determined by the transcription rate of the Epo gene, which itself is essentially under control of the cellular oxygen concentration. Sinks of the oxygen concentrations increase the activity of the hypoxia-inducible transcription factor (HIF), which in turn triggers Epo gene transcription. Disorders of kidney function lead to inappropriate Epo production, what may result in anemia or polycythemia. (C) 2011 American Physiological Society. Compr Physiol 1: 1759-1794, 2011.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available